• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宫颈原位腺癌管理中锥切术的安全性。

The safety of conization in the management of adenocarcinoma in situ of the uterine cervix.

机构信息

Department of Obstetrics and Gynecology, Cheil General Hospital and Women's Healthcare Center, Kwandong University College of Medicine, Seoul, Korea.

出版信息

J Gynecol Oncol. 2011 Mar 31;22(1):25-31. doi: 10.3802/jgo.2011.22.1.25.

DOI:10.3802/jgo.2011.22.1.25
PMID:21607092
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3097330/
Abstract

OBJECTIVE

To evaluate the occurrence of residual or recurrent disease after conization for adenocarcinoma in situ (AIS) of the uterine cervix.

METHODS

Medical records of 99 patients with a histologically diagnosis of AIS of the uterine cervix by conization between 1991 and 2008 were reviewed retrospectively.

RESULTS

Seventy eight of 99 patients (78.8%) had negative and 18 (18.2%) had positive resection margins of the conization specimen, and 3 (3.0%) had unknown margin status. Of the 78 patients with negative margins, 45 underwent subsequent hysterectomy and residual AIS were present in 4.4% (2/45) of patients. Ten of the 18 patients with positive margins received subsequent hysterectomy and 3 patients (30%) had residual AIS. Twenty-eight patients had conservative treatment and during the median follow-up time of 23.5 months (range, 7 to 124 months), only one patient (3.6%) had recurrent AIS and was treated with a simple hysterectomy. Eight patients became pregnant after conization, 4 of them delivered healthy babies, one had a spontaneous abortion and 3 were ongoing pregnancies.

CONCLUSION

Patients with positive resection margins after conization for AIS of the uterine cervix are significantly more likely to have residual disease. However, negative resection margin carries a lower risk for residual AIS, therefore conservative management with careful surveillance seems to be feasible in women who wish to preserve their fertility.

摘要

目的

评估子宫颈原位腺癌(AIS)锥切术后残留或复发疾病的发生情况。

方法

回顾性分析了 1991 年至 2008 年间 99 例经组织学诊断为子宫颈 AIS 行锥切术患者的病历。

结果

99 例患者中,78 例(78.8%)锥切标本切缘阴性,18 例(18.2%)切缘阳性,3 例(3.0%)切缘状态不详。78 例切缘阴性患者中,45 例行后续子宫切除术,其中 4.4%(2/45)患者存在残留 AIS。18 例切缘阳性患者中,10 例接受了后续子宫切除术,其中 3 例(30%)存在残留 AIS。28 例患者行保守治疗,中位随访时间为 23.5 个月(范围为 7 至 124 个月),仅 1 例(3.6%)患者复发 AIS,行单纯子宫切除术治疗。8 例患者锥切术后怀孕,其中 4 例分娩健康婴儿,1 例自然流产,3 例仍在妊娠中。

结论

子宫颈 AIS 锥切术后切缘阳性的患者更有可能存在残留疾病。然而,切缘阴性提示残留 AIS 的风险较低,因此对于希望保留生育能力的患者,行保守治疗并密切监测似乎是可行的。

相似文献

1
The safety of conization in the management of adenocarcinoma in situ of the uterine cervix.宫颈原位腺癌管理中锥切术的安全性。
J Gynecol Oncol. 2011 Mar 31;22(1):25-31. doi: 10.3802/jgo.2011.22.1.25.
2
[Risk stratified management of cervical adenocarcinoma in situ based on cone margin state].基于锥切边缘状态的宫颈原位腺癌风险分层管理
Zhonghua Fu Chan Ke Za Zhi. 2021 Sep 25;56(9):622-629. doi: 10.3760/cma.j.cn112141-20210802-00417.
3
Fertility sparing treatment for in situ and early invasive adenocarcinoma of the cervix.子宫颈原位癌和早期浸润性腺癌的保留生育功能治疗
Obstet Gynecol. 2001 Nov;98(5 Pt 1):726-31. doi: 10.1016/s0029-7844(01)01544-7.
4
The role of loop electrosurgical excisional procedure in the management of adenocarcinoma in situ of the uterine cervix.环形电外科切除术在子宫颈原位腺癌管理中的作用。
Eur J Obstet Gynecol Reprod Biol. 2009 Jul;145(1):100-3. doi: 10.1016/j.ejogrb.2009.04.011. Epub 2009 May 9.
5
Adequacy of conization margins in adenocarcinoma in situ of the cervix as a predictor of residual disease.宫颈原位腺癌锥切切缘的充分性作为残留疾病的预测指标
Gynecol Oncol. 1995 Nov;59(2):179-82. doi: 10.1006/gyno.1995.0003.
6
Risk for residual adenocarcinoma in situ or cervical adenocarcinoma in women undergoing loop electrosurgical excision procedure/conization for adenocarcinoma in situ.接受环形电切术/锥切术治疗原位腺癌的女性发生残留原位腺癌或宫颈腺癌的风险。
J Reprod Med. 2011 Sep-Oct;56(9-10):376-80.
7
Margin Status Post Cervical Conization Predicts Residual Adenocarcinoma In Situ (AIS) and Occult Adenocarcinoma in a Predominantly Hispanic Population.宫颈锥切术后切缘状态可预测以西班牙裔为主的人群中残留的原位腺癌(AIS)及隐匿性腺癌。
Diagnostics (Basel). 2021 Oct 13;11(10):1889. doi: 10.3390/diagnostics11101889.
8
Conservative management of adenocarcinoma in situ of the cervix.宫颈原位腺癌的保守治疗
Gynecol Oncol. 2000 Oct;79(1):6-10. doi: 10.1006/gyno.2000.5962.
9
Clinical outcomes of patients with adenocarcinoma in situ of the cervix treated by conization.宫颈原位腺癌患者锥形切除术后的临床结局
Eur J Gynaecol Oncol. 2014;35(6):641-5.
10
Clinicopathologic features of early adenocarcinoma of the cervix initially managed with cervical conization.最初采用宫颈锥切术治疗的早期宫颈癌的临床病理特征
Gynecol Oncol. 2006 Dec;103(3):960-5. doi: 10.1016/j.ygyno.2006.05.041. Epub 2006 Jul 24.

引用本文的文献

1
Diagnosis and Management of Adenocarcinoma in Situ: A Society of Gynecologic Oncology Evidence-Based Review and Recommendations.《原位腺癌的诊断与管理:妇科肿瘤学学会循证综述与推荐》。
Obstet Gynecol. 2020 Apr;135(4):869-878. doi: 10.1097/AOG.0000000000003761.
2
Oncological and reproductive outcomes of adenocarcinoma in situ of the cervix managed with the loop electrosurgical excision procedure.宫颈原位腺癌行环形电切术的肿瘤学和生殖结局。
BMC Cancer. 2018 Apr 24;18(1):461. doi: 10.1186/s12885-018-4386-6.
3
Cytological variations and typical diagnostic features of endocervical adenocarcinoma in situ: A retrospective study of 74 cases.宫颈原位腺癌的细胞学变异及典型诊断特征:74例回顾性研究
Cytojournal. 2015 Apr 29;12:8. doi: 10.4103/1742-6413.156081. eCollection 2015.
4
Cervical adenocarcinoma in situ with negative conization margin: negligible or not?宫颈原位腺癌切缘阴性:可忽略不计还是并非如此?
J Gynecol Oncol. 2011 Mar 31;22(1):1-2. doi: 10.3802/jgo.2011.22.1.1.

本文引用的文献

1
The volume perspective: a comparison of two excisional treatments for cervical intraepithelial neoplasia (laser versus LLETZ).体积视角:两种宫颈上皮内瘤变切除术式(激光与 LLETZ)的比较。
BJOG. 2010 Apr;117(5):615-9. doi: 10.1111/j.1471-0528.2010.02501.x. Epub 2010 Feb 15.
2
The increasing frequency of cervical cancer in Korean women under 35.韩国 35 岁以下女性宫颈癌发病率上升。
Cancer Res Treat. 2008 Mar;40(1):1-5. doi: 10.4143/crt.2008.40.1.1. Epub 2008 Mar 31.
3
Role of high risk-human papilloma virus test in the follow-up of patients who underwent conization of the cervix for cervical intraepithelial neoplasia.高危型人乳头瘤病毒检测在宫颈上皮内瘤变锥切术后患者随访中的作用。
J Gynecol Oncol. 2009 Jun;20(2):86-90. doi: 10.3802/jgo.2009.20.2.86. Epub 2009 Jun 29.
4
The role of loop electrosurgical excisional procedure in the management of adenocarcinoma in situ of the uterine cervix.环形电外科切除术在子宫颈原位腺癌管理中的作用。
Eur J Obstet Gynecol Reprod Biol. 2009 Jul;145(1):100-3. doi: 10.1016/j.ejogrb.2009.04.011. Epub 2009 May 9.
5
Adenocarcinoma in situ of the uterine cervix: a metaanalysis of 1278 patients evaluating the predictive value of conization margin status.子宫颈原位腺癌:对1278例患者进行的荟萃分析,评估锥形切缘状态的预测价值。
Am J Obstet Gynecol. 2009 Feb;200(2):182.e1-5. doi: 10.1016/j.ajog.2008.09.012. Epub 2008 Nov 18.
6
Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia.人乳头瘤病毒感染的流行病学、自然史及其在宫颈肿瘤形成中的型别特异性影响
Vaccine. 2008 Aug 19;26 Suppl 10:K1-16. doi: 10.1016/j.vaccine.2008.05.064.
7
2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ.2006年宫颈上皮内瘤变或原位腺癌女性管理共识指南
J Low Genit Tract Dis. 2007 Oct;11(4):223-39. doi: 10.1097/LGT.0b013e318159408b.
8
Cervical adenocarcinoma in situ: the predictive value of conization margin status.宫颈原位腺癌:锥切切缘状态的预测价值
Am J Obstet Gynecol. 2007 Aug;197(2):195.e1-7; discussion 195.e7-8. doi: 10.1016/j.ajog.2007.04.035.
9
Cold knife versus laser cone biopsy for adenocarcinoma in situ of the cervix--a comparison of management and outcome.宫颈原位腺癌的冷刀与激光锥形活检——管理与结果的比较
Int J Gynecol Cancer. 2008 Jan-Feb;18(1):116-20. doi: 10.1111/j.1525-1438.2007.00976.x. Epub 2007 May 15.
10
Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix.人乳头瘤病毒(HPV)检测和巴氏涂片检查作为子宫颈原位腺癌(AIS)保守治疗预后的预测指标。
Gynecol Oncol. 2007 Jul;106(1):170-6. doi: 10.1016/j.ygyno.2007.03.016. Epub 2007 May 4.